Cutler Group LP Alector, Inc. Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Jan 18, 2022	SELL	$19.35 - $25.54 $32,895 - $43,418	-1,700 Reduced 65.38%	900 $0
Q3 2021 Oct 26, 2021	BUY	$21.65 - $39.49 $51,960 - $94,776	2,400 Added 1200.0%	2,600 $3,000
Q1 2021 Apr 26, 2021	SELL	$14.84 - $22.23 $7,420 - $11,115	-500 Reduced 71.43%	200 $1,000
Q4 2020 Jan 21, 2021	SELL	$9.4 - $16.7 $49,820 - $88,510	-5,300 Reduced 88.33%	700 $1,000
Q3 2020 Oct 27, 2020	SELL	$10.54 - $24.96 $121,209 - $287,040	-11,500 Reduced 65.71%	6,000 $0
Q2 2020 Jul 22, 2020	BUY	$21.87 - $33.11 $168,399 - $254,947	7,700 Added 78.57%	17,500 $19,000
Q1 2020 May 07, 2020	BUY	$16.25 - $35.28 $159,250 - $345,744	9,800 New	9,800 $26,000

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.